Industry Information

Urokinase manufacturers: the industry welcomes new benefits

  According to the recent "Notice on Announcing the Proposed Price Increases for Dynamic Adjustments of Drugs' Online Prices", there are 136 drugs that are expected to increase their prices through statistics, and the drugs with a price increase of more than 100 are relatively the fewest. There are only 3 varieties, namely injection Urokinase, Bleomycin Saline for Injection, and Pingyangmycin Hydrochloride for Injection. Among them, the price of 250,000 units of urokinase for injection rose from 74.9 yuan to 498 yuan, an increase of 564.89%!

Urokinase manufacturers: the industry welcomes new benefits

  After the news about the price increase of various medicines exploded among the media, the price increase indicated that the price was the proposed adjustment price declared by the enterprise itself, not the final price, but it also mentioned that the country’s easily-shortage drugs are allowed to be declared by the enterprise voluntarily Price adjustment, among which the shortage of drugs includes urokinase. Shortage drugs such as urokinase allow companies to actively declare within a reasonable range and make dynamic adjustments to ensure reasonable profits for companies, which is conducive to improving the clinical supply of shortage drugs and low-priced drugs.

  The price increase of urokinase for injection is so big that although it is rare, it is also reasonable. The person in charge of Jiudong said: the shortage of urokinase has always existed. In 2012, the focus interview made a special report on the shortage of urokinase, which also attracted public attention, but nearly ten years have passed, and the problem of urokinase shortage has not been alleviated but has become a more urgent problem. On December 30, 2020, urokinase was listed by the Department of Drug Administration as a national key monitoring list of clinically necessary and vulnerable drugs ([2020] No. 25 document). Subsequently, Guizhou, Guangdong, Hubei, Jiangxi, Gansu, Shandong, Hainan, Jiangsu, In Shaanxi, Hainan, Ningxia, and other provinces, urokinase is included in the list of shortage drugs and list of shortage drugs.

  Urokinase for injection is a thrombolytic drug, mainly used for thrombolytic therapy of thromboembolic diseases, and it is a kind of urgent rescue drug in short supply.